Neurology News

The CDC has awarded $279 million to 49 states, the District of Columbia and 40 local health departments to address rising drug overdoses in communities, the agency announced.

Long-term exposure to extreme heat can lead to cognitive decline, according to experts.

As physicians age, they should consider the reallocation of their assets into increasingly conservative investments to best limit their exposure to loss.

A Philadelphia-area contract research organization has announced completion of a phase 1 clinical trial of CMX-2043, Ischemix Inc.’s novel, proprietary cytoprotective drug candidate to treat acute traumatic brain injury.

Machine learning may be an effective tool for screening individuals who develop REM sleep behavior disorder and subsequent neurodegenerative conditions, Yoav N. Nygate, said in this Healio video.

Young brain donors exposed to repetitive head impacts through contact sports displayed cognitive and neurobehavioral symptoms with or without a diagnosis of chronic traumatic encephalopathy, according to research from JAMA Neurology.

Artificial intelligence could help clinicians address the social needs of patients with dementia, according to Elham Mahmoudi, PhD.

A Southern California-based bioscience firm has announced additional positive data on FDA-approved Ingrezza capsules to treat adults with chorea associated with Huntington’s disease.

Tracking data from white matter lesions on structural imaging via a circuit-based approach may assist in prognosis of memory and other higher order deficits for those with multiple sclerosis, per research published in Journal of Neurology.

A nurse-delivered sleep restricted therapy intervention within primary care was associated with decreased insomnia severity compared with sleep hygiene and likely cost-effective, according to results of a randomized controlled trial.